Boehringer Ingelheim. (11/4/19). "Press Release: Boehringer Ingelheim and Lilly Modernise Alliance to Focus Full Expertise on Jardiance". Ingelheim & Indianapolis, IN. |
2019-11-04 |
Roivant Sciences GmbH. (10/31/19). "Press Release: Sumitomo Dainippon Pharma and Roivant Sciences Sign Definitive Agreement for Strategic Alliance". Tokyo, Osaka, London & Basel. |
2019-10-31 |
genOway S.A.. (10/30/19). "Press Release: The Institut Pasteur and Cellectis Extend Exclusive License Rights by Granting genOway the Authority to Take Action against Infringement". Lyon & Paris. |
2019-10-30 |
Themis Bioscience GmbH. (10/29/19). "Press Release: Themis Bioscience and CEPI Announce Initiation of Phase 1 Clinical Trial with Lassa Fever Vaccine". Vienna & Oslo. |
2019-10-29 |
Boehringer Ingelheim. (10/29/19). "Press Release: Boehringer Ingelheim Advances First Pan-KRAS Inhibitor BI 1701963 into Clinical Testing". Ingelheim. |
2019-10-29 |
CEM Corporation. (10/29/19). "Press Release: CEM Corporation Acquires Key Assets of Intavis Bioanalytical Instruments". Matthews, NC. |
2019-10-29 |
MorphoSys AG. (10/28/19). "Press Release: MOR106 Clinical Development in Atopic Dermatitis Stopped for Futility". Planegg & Mechelen. |
2019-10-28 |
OpGen, Inc.. (10/28/19). "Press Release: OpGen Announces Closing of $9.4 Million Underwritten Public Offering". Gaithersburg, MD. |
2019-10-28 |
Curetis N.V.. (10/28/19). "Press Release: Curetis Group Company Ares Genetics Launches AI-powered Molecular Antibiotic Susceptibility Test". Vienna & Holzgerlingen. |
2019-10-28 |
CRISPR Therapeutics AG. (10/28/19). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2019 Financial Results". Zug & Cambridge, MA. |
2019-10-28 |
Centogene B.V.. (10/28/19). "Press Release: Centogene Announces Proposed Initial Public Offering of Common Shares". Cambridge, MA & Rostock. |
2019-10-28 |
Editas Medicine, Inc.. (10/28/19). "Press Release: Editas Medicine Appoints Judith R. Abrams, M.D., as Chief Medical Officer". Cambridge, MA. |
2019-10-28 |
Evotec SE. (10/23/19). "Press Release: Evotec, Integra Holdings and Yissum Establish LAB555 to Fast Track Early-stage Drug Development". Hamburg. |
2019-10-23 |
OpGen, Inc.. (10/23/19). "Press Release: OpGen Announces Pricing of $9.4 Million Underwritten Offering". Gaithersburg, MD. |
2019-10-23 |
MCG Motion Capture GmbH. (10/22/19). "Press Release: Motion Capture Group Retains Biotech Alliances International to Raise Series A $15 Million Financing Round". Heidelberg & San Francisco, CA. |
2019-10-22 |
PhagoMed Biopharma GmbH. (10/22/19). "Press Release: Phage Lysin Stabilzes Vaginal Microbiome. PhageMed Accelerates R6D Program against Bacterial Vaginosis". Vienna. |
2019-10-22 |
Bluebird Bio, Inc.. (10/22/19). "Press Release: European Medicines Agency Approves Refined Commercial Manufacturing Specifications for Zynteglo". Cambridge, MA. |
2019-10-22 |
Cision Ltd.. (10/22/19). "Press Release: Cision Ltd. Announces Agreement to Be Acquired by an Affiliate of Platinum Equity for $10.00 Per Share in All Cash Deal Valued at Approximately $2.74 Billion". Chicago. |
2019-10-22 |
Danaher Corporation. (10/21/19). "Press Release: Danaher Reaches Agreement to Sell Certain Businesses to Sartorius AG as Part of the GE Biopharma Acquisition Regulatory Process". Washington, DC. |
2019-10-21 |
Biocat. (10/21/19). "Press Release: Boehringer Ingelheim Joins the d·HEALTH Barcelona Program to Foster Innovation in Health". Barcelona. |
2019-10-21 |
CRISPR Therapeutics AG. (10/21/19). "Press Release: CRISPR Therapeutics and Bayer Announce an Update on Casebia Therapeutics". Leverkusen, Zug & Cambridge, MA. |
2019-10-21 |
Arcutis Biotherapeutics, Inc.. (10/21/19). "Press Release: Arcutis Announces the Completion of $94.5 Million Series C Financing". Westlake Village, CA. |
2019-10-21 |
Sartorius AG. (10/21/19). "Press Release: Sartorius Signs Agreement to Acquire Select Danaher Life Science Platform Businesses". Göttingen. |
2019-10-21 |
Merck KGaA. (10/18/19). "Press Release: Merck Launches Seed Fund for Startups in China". Darmstadt. |
2019-10-18 |
Avacta Group plc. (10/18/19). "Press Release: Proposed Placing and Subscription to Raise up to £9 Million and Notice of General Meeting". |
2019-10-18 |
Sofinnova Partners. (10/17/19). "Press Release: Sofinnova Partners Raises €333 Million Capital IX Early-stage Healthcare Fund". Paris. |
2019-10-17 |
Plexium, Inc.. (10/17/19). "Press Release: Plexium Launches with $28 Million in Series A Financing". San Diego, CA. |
2019-10-17 |
HepaRegenix GmbH. (10/17/19). "Press Release: HepaRegenix GmbH Announces Management Changes. Dr. Michael Lutz Appointed as New CEO/Managing Director". Tübingen. |
2019-10-17 |
Versameb AG. (10/17/19). "Press Release: Versameb Raises CHF 6.4 Million in Seed C Round and Strengthens the Team". Basel. |
2019-10-17 |
Healx Ltd.. (10/16/19). "Press Release: Healx Secures $56m in Series B Financing, Launches Global Accelerator Programme for Rare Diseases". Cambridge. |
2019-10-16 |
Abalos Therapeutics GmbH. (10/15/19). "Press Release: Abalos Therapeutics Launches with €12M Series A Round to Develop Novel Immuno-Virotherapies Against Cancer". Essen. |
2019-10-15 |
CRISPR Therapeutics AG. (10/15/19). "Press Release: CRISPR Therapeutics and KSQ Therapeutics Announce License Agreement to Advance Companies’ Respective Cell Therapy Programs in Oncology". Zug & Cambridge, MA. |
2019-10-15 |
Numab Therapeutics AG. (10/15/19). "Press Release: Numab Appoints Daniel Vasella to Board of Directors". Wädenswil (Zurich). |
2019-10-15 |
MorphoSys AG. (10/14/19). "Press Release: MorphoSys and I-Mab Biopharma Announce IND Clearance to Initiate Clinical Trials of MOR202/TJ202 for the Treatment of Multiple Myeloma in Mainland China". Planegg & Shanghai. |
2019-10-14 |
BioNTech SE. (10/10/19). "Press Release: BioNTech Announces Pricing of Initial Public Offering". Mainz. |
2019-10-10 |
Bayer AG. (10/10/19). "Press Release: Bayer Launches LifeHub UK Focused on Artificial Intelligence to Optimize Data-driven Drug discovery and Disease Diagnosis". Leverkusen & Reading. |
2019-10-10 |
Evotec SE. (10/10/19). "Press Release: Just-Evotec Biologics and Biocon Biologics Sign Licensing Deal for a Biosimilar Asset". Hamburg, Seattle, WA & Bengaluru. |
2019-10-10 |
Merck KGaA. (10/10/19). "Press Release: Merck Becomes the First to Use Acoustic Technology for Cell Therapy Manufacturing". Darmstadt. |
2019-10-10 |
Stilla Technologies S.A.S.. (10/10/19). "Press Release: Stilla Technologies Opens U.S. Subsidiary for Direct Commercial Operations Under the Leadership of Life Science Veteran". Beverly, MA. |
2019-10-10 |
Evotec SE. (10/9/19). "Press Release: Evotec and Celmatix Enter into Strategic Collaboration". Hamburg & New York, NY. |
2019-10-09 |
iOmx Therapeutics AG. (10/9/19). "Press Release: iOmx Therapeutics Strengthens Executive Management Team and Supervisory Board". Martinsried. |
2019-10-09 |
Roivant Sciences GmbH. (10/9/19). "Press Release: Parexel and Datavant Enter Multi-Year Strategic Partnership to Enable the Connection of Real-World Data Across All Parexel Clinical Trials". Boston, MA & San Francisco, CA. |
2019-10-09 |
GlaxoSmithKline plc. (10/8/19). "Press Release: GSK and Lyell Immunopharma Join Forces to Develop the Next Generation of Cancer Cell Therapies". London & San Francisco, CA. |
2019-10-08 |
Vivoryon Therapeutics AG. (10/8/19). "Press Release: Vivoryon Therapeutics AG Launches Rights Offering to Fund its Phase 2b Clinical Development Program in Alzheimer’s Disease with Strong Commitments [Not for US, et al.]". Halle (Saale). |
2019-10-08 |
Bayer AG. (10/8/19). "Press Release: Bayer and RIKEN Innovation Establish Partnership in Drug Discovery". Osaka & Tokyo. |
2019-10-08 |
EOS GmbH. (10/8/19). "Press Release: Marie Langer Appointed New CEO of EOS GmbH". Krailing. |
2019-10-08 |
Illumina, Inc.. (10/7/19). "Press Release: Illumina and Qiagen Partner to Deliver Sequencing-Based In-Vitro Diagnostic (IVD) Tests". San Diego, CA & Hilden & Germantown, MD. |
2019-10-07 |
Qiagen N.V.. (10/7/19). "Press Release: Qiagen Announces CEO Leadership Transition. Peer M. Schatz to Step Down as CEO to Pursue New Opportunities". Venlo. |
2019-10-07 |
Dalhousie University. (10/7/19). "Press Release: Molly Appeal to Help Fund Orbitrap Fusion, Boosting Cancer, Brain, Immunity Research". |
2019-10-07 |
Qiagen N.V.. (10/7/19). "Press Release: Qiagen Reports Preliminary Q3 2019 Results and Announces Measures to Prioritize Resource Allocation". Venlo. |
2019-10-07 |
LeadXPro AG. (10/7/19). "Press Release: LeadXPro and Lundbeck enter Strategic Partnership on Membrane Protein Structure Research". Villigen. |
2019-10-07 |
Rentschler Biopharma SE. (10/4/19). "Press Release: Rentschler Biopharma Announces Enhanced Collaboration with Summit Pharmaceuticals International Corporation to Expand Japanese Operation-Base". Laupheim & Milford, MA. |
2019-10-04 |
Aeovian Pharmaceuticals Inc.. (10/3/19). "Press Release: Aeovian Pharmaceuticals Raises $37 Million Series A Financing to Advance Selective mTORC1 Inhibitors into the Clinic for Rare and Age-Related Diseases". San Francisco, CA. |
2019-10-03 |
BaseLaunch (BaselArea.swiss). (10/3/19). "Press Release: 15 Companies Chosen for Phase 1". Basel. |
2019-10-03 |
ADC Therapeutics S.A.. (10/2/19). "Press Release: ADC Therapeutics Announces Withdrawal of Registration Statement". Lausanne. |
2019-10-02 |
Bruker Corporation. (10/2/19). "Press Release: Bruker Announces Acquisition of Magnettech’s EPR Business". Freiberg. |
2019-10-02 |
Novartis AG. (10/1/19). "Press Release: Novartis and Microsoft Announce Collaboration to Transform Medicine with Artificial Intelligence". Basel & Redmond, WA. |
2019-10-01 |
ProBioGen AG. (10/1/19). "Press Release: ProBioGen and Ceva Santé Animale Sign an Exclusive License Agreement to Produce Vectorised Poultry Vaccines Using AGE1.CR Production Technology". Berlin. |
2019-10-01 |
Numab Therapeutics AG. (10/1/19). "Press Release: Numab and Eisai Enter into a Global Research and Option Agreement to Discover and Develop Multi-specific Antibody Immunotherapies for Cancer". Tokyo & Zurich. |
2019-10-01 |
Bayer AG. (10/1/19). "Press Release: Bayer and Arvinas Unveil Targeted Protein Degradation Joint Venture, Oerth Bio". Monheim, Boston, MA & New Haven, CT. |
2019-10-01 |
Cellectis S.A.. (10/1/19). "Press Release: Cellectis and Lonza Enter cGMP Manufacturing Service Agreement for Cellectis’ Allogeneic UCART Product Candidates". Basel & New York, NY. |
2019-10-01 |
Creoptix AG. (9/30/19). "Press Release: Creoptix Closes Successful Series C Financing Round to Support Further Growth". Wädenswil (Zurich). |
2019-09-30 |
Arix Bioscience plc. (9/30/19). "Press Release: Arix Co-leads EUR 20 Million Series A Investment Round in STipe Therapeutics". London. |
2019-09-30 |
BCNP Consultants GmbH. (9/27/19). "Press Release: 2nd ECP Summer Summit at Henkel HQ, Düsseldorf". Düsseldorf & Frankfurt a. M.. |
2019-09-27 |
AMETEK, Inc.. (9/27/19). "Press Release: Ametek to Acquire Gatan from Roper Technologies". Berwyn, PA & Sarasota, FL. |
2019-09-27 |
BASF SE. (9/27/19). "Press Release: BASF’s Strategy in Agriculture Aims for Innovation-driven Growth in Specific Markets". |
2019-09-27 |
T3 Pharmaceuticals AG. (9/26/19). "Press Release: Closing of Financing Round and Strengthening of Development Team Paves the Way for T3 Pharma to Enter the Clinic". |
2019-09-26 |
Eppendorf AG. (9/26/19). "Press Release: Eppendorf Significantly Expands Production Site in Oldenburg". Hamburg & Oldenburg in Holstein. |
2019-09-26 |
Adrenomed AG. (9/26/19). "Press Release: Adrenomed Completes Full Enrollment with 300 Patients in AdrenOSS-2 Trial with Adrecizumab in Septic Shock". Hennigsdorf. |
2019-09-26 |
Thermo Fisher Scientific Inc.. (9/25/19). "Press Release: Thermo Fisher Scientific Prices Offering of Senior Notes". Waltham, MA. |
2019-09-25 |
Tacalyx GmbH. (9/25/19). "Press Release: Tacalyx Raises €7 Million in Seed Funding to Generate First in Class Anti-TACA Antibodies for Cancer Treatment". Berlin. |
2019-09-25 |
BioNTech SE. (9/24/19). "Press Release: BioNTech Announces Commencement of Initial Public Offering". Mainz. |
2019-09-24 |
Evotec SE. (9/24/19). "Press Release: Evotec and Takeda Enter Collaboration Agreement to Discover Clinical Candidates across Multiple Therapeutic Areas". Hamburg. |
2019-09-24 |
Addex Therapeutics S.A.. (9/24/19). "Press Release: Addex Therapeutics Submits Registration Statement with the U.S. SEC to Facilitate Nasdaq Listing of ADSs Representing Shares". Geneva. |
2019-09-24 |
Blueprint Genetics Oy. (9/24/19). "Press Release: Blueprint Genetics and ArchimedLife Form a Partnership to Launch High Quality Biochemical Testing for Rare Diseases in North America". |
2019-09-24 |
ADC Therapeutics S.A.. (9/23/19). "Press Release: ADC Therapeutics Announces Launch of Initial Public Offering". Lausanne. |
2019-09-23 |
Newron Pharmaceuticals S.p.A.. (9/20/19). "Press Release: Newron Pharmaceutical Commercialization Partner Meiji Seika together with Eisai Announce the Approval of Safinamide for Parkinson’s Disease in Japan". Milan. |
2019-09-20 |
Oncimmune Holdings plc. (9/20/19). "Press Release: €8.5m Credit Facility Secured. Funding to Accelerate the Further Commercialisation of Oncimmune’s Lead Products and Services". |
2019-09-20 |
Roche. (9/20/19). "Press Release: FDA Approves cobas Babesia, Roche’s First Whole Blood Test for Donor Screening". Basel. |
2019-09-20 |
Bruker Corporation. (9/20/19). "Press Release: Strategic Alliance between Murdoch University and Bruker Supports International Centre of Excellence in Metabolic Phenotyping". Perth & Billerica, MA. |
2019-09-20 |
Boehringer Ingelheim. (9/20/19). "Press Release: Boehringer Ingelheim Partners with Inflammasome Therapeutics to Develop Novel Therapies for Patients with Retinal Diseases". Ingelheim & Newton, MA. |
2019-09-20 |
AC Immune S.A.. (9/20/19). "Press Release: AC Immune Receives First Milestone Payment from Lilly in Small Molecule Tau Morphomer Program". Lausanne. |
2019-09-20 |
Novigenix S.A.. (9/19/19). "Press Release: Novigenix and BioLizard Sign Collaboration Agreement for Development of NGS Based Diagnostic Algorithm". Lausanne. |
2019-09-19 |
Universität zu Lübeck (UzL). (9/19/19). "Pressemitteilung: Künstliche Intelligenz. Bund empfiehlt Förderung über zehn Millionen Euro". Lübeck. |
2019-09-19 |
Versantis AG. (9/18/19). "Press Release: Versantis Closes CHF 16M Series B Financing Round to Advance Clinical Development of Novel Therapeutics for Liver Diseases". Zürich. |
2019-09-18 |
Divide & Conquer. (9/18/19). "Press Release: Divide & Conquer, Developing New Class of Cancer Therapeutics to Disrupt Cell-to-Cell Communication, Emerges from Stealth as New Paper by Co-Founder is Published in Nature". Cambridge. |
2019-09-18 |
Themis Bioscience GmbH. (9/18/19). "Press Release: Themis Raises EUR 40 Million in Series D Financing Round Backed by US/EU Consortium to Support Pivotal Study and Expand Clinical Pipeline". Vienna. |
2019-09-18 |
Roche. (9/18/19). "Press Release: FDA Grants Breakthrough Therapy Designation for Roche’s Gazyva (obinutuzumab) in Lupus Nephritis". Basel. |
2019-09-18 |
Bayer AG. (9/17/19). "Press Release: Bayer and Informed Data Systems Inc. to Develop One Drop Digital Therapeutics Platform for Multiple Therapeutic Areas [Not intended for U.S. and UK Media]". Berlin. |
2019-09-17 |
BIO Deutschland. (9/17/19). "Pressemittelung: Biotechnologie-Branchenverband wählt neuen Vorstand. 16. Mitgliederversammlung der BIO Deutschland". Berlin. |
2019-09-17 |
CRISPR Therapeutics AG. (9/17/19). "Press Release: CRISPR Therapeutics and ViaCyte Present Positive In Vitro Data Towards a Potential Immune-Evasive Cell Replacement Therapy for Diabetes at EASD 2019". Zug, Cambridge, MA & San Diego, CA. |
2019-09-17 |
AC Immune S.A.. (9/17/19). "Press Release: AC Immune Receives Milestone Payment in Connection with Initiation of a Phase 2 Trial of Tau PET Tracer PI-2620". Lausanne. |
2019-09-17 |
High-Tech Gründerfonds Management GmbH. (9/16/19). "Press Release: Chemistry-for-Healthcare Start-up Secures Seed Investment from Investitionsbank Berlin (IBB) and High-Tech Gründerfonds (HTGF)". |
2019-09-16 |
Bruker Corporation. (9/16/19). "Press Release: Bruker Announces Release of Breakthrough diaPASEF Workflow for CCS-aware 4D Proteomics on timsTOF Pro Platform at HUPO 2019". Adelaide. |
2019-09-16 |
MorphoSys AG. (9/16/19). "Press Release: MorphoSys's Licensee Janssen Submits Biologics License Application to U.S. FDA of Tremfya (Guselkumab) for Treatment of Adults with Active Psoriatic Arthritis". Planegg. |
2019-09-16 |
Curetis N.V.. (9/16/19). "Press Release: Curetis Group Subsidiary Ares Genetics Signs R&D and Option Agreement with Leading Global IVD Corporation". Holzgerlingen & Vienna. |
2019-09-16 |
GenomSys S.A.. (9/16/19). "Press Release: GenomSys, the Swiss Startup Disrupting Genomics Information Handling Closes a CHF 9.3 Million Series A Investment Round". |
2019-09-16 |
Abionic S.A.. (9/13/19). "Press Release: International Pivotal Study Successfully Demonstrates Diagnosis of Sepsis within 5 Minutes – 24 Hours Earlier Compared with Current Standard-of-Care". Lausanne. |
2019-09-13 |
Biocrates Life Sciences AG. (9/12/19). "Press Release: Repositioning of Biocrates – Management Change and New Round of Financing". Innsbruck. |
2019-09-12 |
Max Planck Society. (9/12/19). "Press Release: Launch of Tech Transfer Fund KHAN-I". |
2019-09-12 |